[
    [
        {
            "time": "2020-03",
            "original_text": "【招商策略】2020年3月陆股通持股分析 ——复盘本轮北上资金变动的四个阶段",
            "features": {
                "keywords": [
                    "陆股通",
                    "北上资金",
                    "持股分析",
                    "四个阶段"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "投资"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【招商策略】2020年3月陆股通持股分析 ——复盘本轮北上资金变动的四个阶段",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "药明康德，中国新药研发“卖水人”之王是怎样炼成的？",
            "features": {
                "keywords": [
                    "药明康德",
                    "新药研发",
                    "卖水人"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德，中国新药研发“卖水人”之王是怎样炼成的？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-05",
            "original_text": "清华大学：5月底疫苗和抗体药物均可进入动物试验阶段",
            "features": {
                "keywords": [
                    "清华大学",
                    "疫苗",
                    "抗体药物",
                    "动物试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "清华大学：5月底疫苗和抗体药物均可进入动物试验阶段",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]